Alexander Markoff

Array ( [id] => 6852070 [patent_doc_number] => 20030144273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => '2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity' [patent_app_type] => new [patent_app_number] => 10/180756 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41173 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144273.pdf [firstpage_image] =>[orig_patent_app_number] => 10180756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134857 [patent_doc_number] => 06784173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Aromatic dicarboxylic acid derivatives' [patent_app_type] => B2 [patent_app_number] => 10/167677 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9249 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784173.pdf [firstpage_image] =>[orig_patent_app_number] => 10167677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1131636 [patent_doc_number] => 06787653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-07 [patent_title] => 'Preparation process of biphenylcarboxylic acid amide derivatives' [patent_app_type] => B2 [patent_app_number] => 10/162602 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7774 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787653.pdf [firstpage_image] =>[orig_patent_app_number] => 10162602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761972 [patent_doc_number] => 20030125334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => '5-HT receptor ligands and uses thereof' [patent_app_type] => new [patent_app_number] => 10/163881 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40430 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125334.pdf [firstpage_image] =>[orig_patent_app_number] => 10163881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751002 [patent_doc_number] => 20030045523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Pharmaceutical compositions and methods for use' [patent_app_type] => new [patent_app_number] => 10/162129 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15667 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045523.pdf [firstpage_image] =>[orig_patent_app_number] => 10162129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814134 [patent_doc_number] => 20030073684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Certain benzothiazine dioxide endothelin antagonists and processes for their preparation' [patent_app_type] => new [patent_app_number] => 10/161569 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20079 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073684.pdf [firstpage_image] =>[orig_patent_app_number] => 10161569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1085846 [patent_doc_number] => 06831080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-14 [patent_title] => 'Cinnamide derivatives as KCNQ potassium channel modulators' [patent_app_type] => B2 [patent_app_number] => 10/160582 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40769 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/831/06831080.pdf [firstpage_image] =>[orig_patent_app_number] => 10160582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651856 [patent_doc_number] => 20030105106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => '5-HT receptor ligands and uses thereof' [patent_app_type] => new [patent_app_number] => 10/156884 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28594 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105106.pdf [firstpage_image] =>[orig_patent_app_number] => 10156884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1178032 [patent_doc_number] => 06743785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Agents and methods for the treatment of proliferative diseases' [patent_app_type] => B2 [patent_app_number] => 10/130801 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24597 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 489 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743785.pdf [firstpage_image] =>[orig_patent_app_number] => 10130801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329542 [patent_doc_number] => 20020198194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Quinoline derivatives' [patent_app_type] => new [patent_app_number] => 10/151505 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26650 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198194.pdf [firstpage_image] =>[orig_patent_app_number] => 10151505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792778 [patent_doc_number] => 20030088122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Method of preparing amino carboxylic acids' [patent_app_type] => new [patent_app_number] => 10/151650 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24870 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20030088122.pdf [firstpage_image] =>[orig_patent_app_number] => 10151650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774691 [patent_doc_number] => 20030018029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => new [patent_app_number] => 10/136276 [patent_app_country] => US [patent_app_date] => 2002-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22937 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018029.pdf [firstpage_image] =>[orig_patent_app_number] => 10136276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1123900 [patent_doc_number] => 06794393 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-21 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/110872 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27596 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 858 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794393.pdf [firstpage_image] =>[orig_patent_app_number] => 10110872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048713 [patent_doc_number] => 20020169178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Benzothieno[3,2-c]pyridines as alpha2 antagonists' [patent_app_type] => new [patent_app_number] => 10/123338 [patent_app_country] => US [patent_app_date] => 2002-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5666 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169178.pdf [firstpage_image] =>[orig_patent_app_number] => 10123338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697362 [patent_doc_number] => 20030109556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Melanocortin receptor ligands' [patent_app_type] => new [patent_app_number] => 10/121874 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30685 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109556.pdf [firstpage_image] =>[orig_patent_app_number] => 10121874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360410 [patent_doc_number] => 06573275 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Bicyclic amines' [patent_app_type] => B1 [patent_app_number] => 10/124696 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27950 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573275.pdf [firstpage_image] =>[orig_patent_app_number] => 10124696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818273 [patent_doc_number] => 20030069231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Modified aminoacids, pharmaceuticals containing these compounds and method for their production' [patent_app_type] => new [patent_app_number] => 10/119875 [patent_app_country] => US [patent_app_date] => 2002-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95627 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069231.pdf [firstpage_image] =>[orig_patent_app_number] => 10119875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178072 [patent_doc_number] => 20020156095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => '2-aminoquinolinecarboxamides: neurokinin receptor ligands' [patent_app_type] => new [patent_app_number] => 10/115409 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8491 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156095.pdf [firstpage_image] =>[orig_patent_app_number] => 10115409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096388 [patent_doc_number] => 06821972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => '3-heterocyclylpropanohydroxamic acid PCP inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/112338 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47386 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821972.pdf [firstpage_image] =>[orig_patent_app_number] => 10112338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756435 [patent_doc_number] => 20030004212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists' [patent_app_type] => new [patent_app_number] => 10/108086 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26182 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004212.pdf [firstpage_image] =>[orig_patent_app_number] => 10108086 [rel_patent_id] =>[rel_patent_doc_number] =>)